Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1994 Sep 13;91(19):8827-31.
doi: 10.1073/pnas.91.19.8827.

Cellular signaling by an agonist-activated receptor/Gs alpha fusion protein

Affiliations

Cellular signaling by an agonist-activated receptor/Gs alpha fusion protein

B Bertin et al. Proc Natl Acad Sci U S A. .

Abstract

The consequences of agonist-dependent activation of guanine nucleotide-binding protein (G protein)-coupled receptors vary from cell to cell, depending on a complex network of regulations between components of the signaling cascade. Specific interactions between receptors, G proteins, and effectors are difficult to analyze in intact cells. Engineering of receptor-transducer fusion proteins might be an effective strategy to target cellular effectors more efficiently and specifically. As a model, we evaluated the ability of a fusion protein of beta 2-adrenergic receptor bound to the alpha subunit of adenylyl cyclase-stimulatory G protein (Gs alpha) to restore the defective activation of adenylyl cyclase in S49 cyc- cells that lack endogenous Gs alpha. The coupling between the two partners of the fusion protein was functional, and the agonist-dependent activation of the effector was more potent and more productive in transfected than in wild-type S49 cells. The covalent link between receptor and Gs alpha could thus convey an advantage over freely interacting components. Such receptor-G alpha fusion proteins may help to elucidate the complex interactions between members of signaling pathways and may also constitute a useful tool for studying the effects of single effector activation.

PubMed Disclaimer

References

    1. J Biol Chem. 1989 Dec 25;264(36):21907-14 - PubMed
    1. Clin Exp Immunol. 1989 Oct;78(1):42-8 - PubMed
    1. FASEB J. 1990 Aug;4(11):2881-9 - PubMed
    1. J Biol Chem. 1991 May 15;266(14):9009-15 - PubMed
    1. Science. 1991 May 10;252(5007):802-8 - PubMed

Publication types